**Core Concept:** Breast lesions can be classified into benign, premalignant, or malignant based on their potential for progression. Benign lesions do not have the potential to become malignant, premalignant lesions have the potential to become malignant, and malignant lesions are already considered cancerous.
**Why the Correct Answer is Right:** The correct answer, **Option C: Fibroadenoma**, is selected due to its potential for progression to a malignant lesion. Fibroadenomas are the most common benign breast lesions in women, consisting of both stromal and epithelial components. While most fibroadenomas remain benign, there is a small risk of malignant change, particularly in older individuals or those with a familial predisposition to breast cancer.
**Why Each Wrong Option is Incorrect:**
A. **Option A: Benign Neoplasm**: Benign neoplasms are non-cancerous tumors that do not have the potential to spread to other parts of the body. They do not progress to malignancy.
B. **Option B: Premenopausal Breast Cyst**: Premenopausal breast cysts are fluid-filled sacs in the breast that can cause symptoms like pain or swelling. Although they are benign, they do not progress to malignancy.
C. **Option C: Fibroadenoma**: As mentioned earlier, fibroadenomas have a potential for malignant change, making them a pre-malignant lesion.
D. **Option D: Malignant Lesion**: Malignant lesions, also known as cancers, are cancerous and have the potential to spread to other parts of the body. They are not the correct answer because the question asks for the lesion with the greatest potential for progression to malignancy, which is Option C: Fibroadenoma.
**Clinical Pearl:** Regular screening and monitoring of fibroadenomas, especially in high-risk individuals, is crucial to detect any malignant changes early, allowing for prompt treatment and improved prognosis.
**Correct Answer:** Option C: Fibroadenoma
Free Medical MCQs Β· NEET PG Β· USMLE Β· AIIMS
Access thousands of free MCQs, ebooks and daily exams.
By signing in you agree to our Privacy Policy.